BAM
SNY icon

Bruderman Asset Management’s Sanofi SNY Stock Holding History

Bruderman Asset Management’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$783K Sell
15,651
-910
-5% -$48.3K 1.41% 29
2022
Q1 		$846K Sell
16,561
-14,830
-47% -$766K 1.28% 30
2021
Q4 		$1.57M Sell
31,391
-38,123
-55% -$1.89M 1.2% 26
2021
Q3 		$3.35M Buy
69,514
+1,005
+1% +$51.1K 0.84% 41
2021
Q2 		$3.61M Buy
68,509
+1,448
+2% +$75.6K 1.12% 34
2021
Q1 		$3.32M Buy
67,061
+462
+0.7% +$22.2K 0.92% 37
2020
Q4 		$3.24M Buy
66,599
+2,793
+4% +$138K 0.94% 38
2020
Q3 		$3.2M Sell
63,806
-5,261
-8% -$271K 1.05% 33
2020
Q2 		$3.54M Buy
69,067
+2,494
+4% +$121K 1.17% 34
2020
Q1 		$2.86M Sell
66,573
-2,560
-4% -$122K 1.13% 31
2019
Q4 		$3.5M Sell
69,133
-5,827
-8% -$273K 1.09% 39
2019
Q3 		$3.44M Sell
74,960
-5,533
-7% -$239K 0.87% 46
2019
Q2 		$3.48M Buy
80,493
+843
+1% +$35.8K 0.82% 45
2019
Q1 		$3.53M Sell
79,650
-424
-0.5% -$18.2K 0.77% 42
2018
Q4 		$3.48M Sell
80,074
-4,280
-5% -$189K 0.9% 39
2018
Q3 		$3.77M Sell
84,354
-33,804
-29% -$1.44M 0.86% 45
2018
Q2 		$4.73M Buy
118,158
+24,311
+26% +$957K 1.15% 29
2018
Q1 		$3.76M Sell
93,847
-2,508
-3% -$104K 0.9% 39
2017
Q4 		$4.14M Sell
96,355
-3,347
-3% -$154K 1.05% 34
2017
Q3 		$4.96M Sell
99,702
-44,735
-31% -$2.16M 1.28% 25
2017
Q2 		$6.92M Sell
144,437
-61,243
-30% -$2.93M 1.85% 17
2017
Q1 		$9.31M Buy
205,680
+51,081
+33% +$2.17M 2.69% 14
2016
Q4 		$6.25M Buy
154,599
+8,759
+6% +$345K 1.88% 17
2016
Q3 		$5.57M Sell
145,840
-38,767
-21% -$1.56M 1.66% 21
2016
Q2 		$7.73M Buy
184,607
+6,324
+4% +$259K 2.42% 12
2016
Q1 		$7.16M Buy
178,283
+6,955
+4% +$279K 2.49% 13
2015
Q4 		$7.31M Buy
171,328
+2,018
+1% +$92.8K 2.75% 10
2015
Q3 		$8.04M Buy
169,310
+26,700
+19% +$1.36M 3.17% 9
2015
Q2 		$7.06M Buy
142,610
+37,145
+35% +$1.88M 2.71% 12
2015
Q1 		$5.21M Buy
+105,465
New +$5.04M 2.03% 16

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Bruderman Asset Management's SNY Position: Q2 2022 in Review

Bruderman Asset Management reduced its Sanofi (SNY) stake by 5.5% in Q2 2022, selling an estimated $48.3K and leaving 15,651 shares worth $783K. The position accounts for 1.41% of the portfolio, ranked #29.

Bruderman Asset Management first reported a position in SNY in Q1 2015 and has held it in 30 quarters since. The position peaked at $9.31M in Q1 2017. 655 funds tracked by Wall St. Rank hold SNY as of Q2 2022.

  • Bruderman Asset Management held 15,651 shares of Sanofi worth $783K as of Q2 2022.
  • Bruderman Asset Management sold 910 Sanofi shares in Q2 2022, an estimated $48.3K.
  • Sanofi made up 1.41% of Bruderman Asset Management's portfolio in Q2 2022, its #29 holding.
  • Bruderman Asset Management first reported a position in Sanofi in Q1 2015 and has held it in 30 quarters since.
  • Bruderman Asset Management's Sanofi position peaked at $9.31M in Q1 2017.
  • 655 funds tracked by Wall St. Rank held Sanofi as of Q2 2022.

Based on Bruderman Asset Management's 13F filing for Q2 2022, filed 15 Aug 2022.